|Bid||83.50 x 1100|
|Ask||83.55 x 1100|
|Day's Range||83.35 - 83.80|
|52 Week Range||65.44 - 88.76|
|Beta (3Y Monthly)||0.81|
|PE Ratio (TTM)||51.33|
|Earnings Date||Oct 15, 2019 - Oct 21, 2019|
|Forward Dividend & Yield||1.28 (1.54%)|
|1y Target Est||94.32|
ABBOTT PARK, Ill., Sept. 18, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2019 financial results on Wednesday, Oct. 16, 2019 , before the market opens. The announcement will ...
The Masters HP™ 15mm rotatable mechanical heart valve and the Amplatzer Piccolo™ Occluder have received CE Mark and are now available in Europe and other countries that recognize CE Mark. Congenital heart defects (CHD) affect approximately 36,000 births in the European Union each year.i The Masters valve is the world's smallest mechanical heart valve and allows doctors to treat babies and toddlers in need of a mitral or aortic heart valve replacement.
ABBOTT PARK, Ill., Sept. 16, 2019 /PRNewswire/ -- Abbott (ABT) has been named the Global Industry Leader in sustainability for the seventh consecutive year by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability. As the industry leader in Health Care Equipment & Supplies, the company earned top scores across all three key areas, including economic, social and environmental performance.
With this reimbursement approval, Abbott's (ABT) FreeStyle Libre becomes the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada.
ABBOTT PARK, Ill. and PARIS, Sept. 16, 2019 /PRNewswire/ -- Abbott (ABT) and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with Sanofi′s insulin dosing information for future smart pens, insulin titration apps and cloud software. "As the global leader in continuous glucose monitoring, we see a significant opportunity to impact the health of millions of people living with diabetes by developing new tools and connectivity with Sanofi, a leader in the insulin space," said Jared Watkin, senior vice president, Diabetes Care, Abbott.
Hoy Health launched less than two years ago, but sees strong growth potential in paving the way to the Latin American health care market.
ABBOTT PARK, Ill., Sept. 13, 2019 /PRNewswire/ -- Abbott (ABT), the global leader in sensor-based glucose monitoring, announced today that it has received public reimbursement in Ontario and Quebec for its FreeStyle® Libre system, becoming the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada. Quebec residents 18 years or older2 and Ontario residents using insulin are eligible for reimbursement under the public programs. With its proven accuracy and ease of use,3 the FreeStyle Libre system replaces traditional blood glucose monitoring and allows patients to dose insulin based on the results.
ABBOTT PARK, Ill., Sept. 12, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share. This marks the 383 rd consecutive quarterly ...
- New research found Abbott's algorithm created through machine learning could give doctors a more individualized calculation, leveraging factors such as age, sex and the changing dynamics of troponin ...
Given the lack of an alternative therapy to replace tricuspid regurgitation surgery, Abbott (ABT) should be at an advantage in this space.
KIGALI, Rwanda, Sept. 9, 2019 /PRNewswire/ -- The Ministry of Health of Rwanda, the non-profit organization Society for Family Health Rwanda and global healthcare company Abbott (ABT) are today announcing the grand opening of a second-generation health post in Gikundamvura Cell, Ruhuha Sector, Bugesera District. The new health post is part of a program to help bring accessible, affordable and enhanced quality health services to rural communities in Rwanda.
ABBOTT PARK, Ill., Sept. 6, 2019 /PRNewswire/ -- Abbott (ABT) announced today that it is teaming up with NFL star, Cleveland Browns wide receiver, and Pedialyte® fan, Odell Beckham Jr., to serve as a creative director and ambassador for Pedialyte. Known for more than 50 years as a go-to for rehydration, Pedialyte—which is found in the baby aisle—has, over the last few years, seen unprecedented use by consumers of all ages, including athletes, who rely on it for advanced rehydration.
Miles White has been the CEO of Abbott Laboratories (NYSE:ABT) since 1999. First, this article will compare CEO...
So far, the levies and prospect of additional tariffs have not cooled investors’ enthusiasm for the shares of industry members Continue reading...
Women make up less than a quarter of the stem workforce in the United States. That's why Corlis Murray of Abbott Laboratories says her company is on a mission to change that number. She breaks it down to Yahoo Finance's Julie Hyman, Adam Shapiro, and Rick Newman.